Wisconsin Capital Management LLC Takes $1.52 Million Position in Medtronic PLC (MDT)

Wisconsin Capital Management LLC acquired a new position in shares of Medtronic PLC (NYSE:MDT) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 16,750 shares of the medical technology company’s stock, valued at approximately $1,524,000.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Banco Santander S.A. boosted its holdings in Medtronic by 0.6% during the fourth quarter. Banco Santander S.A. now owns 35,971 shares of the medical technology company’s stock worth $3,272,000 after buying an additional 209 shares in the last quarter. Employees Retirement System of Texas raised its position in Medtronic by 10.4% during the fourth quarter. Employees Retirement System of Texas now owns 442,000 shares of the medical technology company’s stock worth $40,204,000 after acquiring an additional 41,550 shares during the last quarter. Polen Capital Management LLC raised its position in Medtronic by 19.6% during the fourth quarter. Polen Capital Management LLC now owns 83,735 shares of the medical technology company’s stock worth $7,617,000 after acquiring an additional 13,730 shares during the last quarter. Northern Trust Corp raised its position in Medtronic by 4.3% during the fourth quarter. Northern Trust Corp now owns 16,526,215 shares of the medical technology company’s stock worth $1,503,225,000 after acquiring an additional 688,537 shares during the last quarter. Finally, Burney Co. raised its position in Medtronic by 4.7% during the fourth quarter. Burney Co. now owns 10,212 shares of the medical technology company’s stock worth $929,000 after acquiring an additional 462 shares during the last quarter. 80.59% of the stock is currently owned by hedge funds and other institutional investors.

In related news, CEO Omar Ishrak bought 12,000 shares of the stock in a transaction that occurred on Wednesday, January 9th. The stock was purchased at an average cost of $84.05 per share, for a total transaction of $1,008,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Karen L. Parkhill bought 3,000 shares of the stock in a transaction that occurred on Wednesday, January 9th. The stock was bought at an average price of $83.87 per share, with a total value of $251,610.00. The disclosure for this purchase can be found here. Insiders own 0.28% of the company’s stock.

MDT has been the subject of a number of research reports. Citigroup cut shares of Medtronic from a “buy” rating to a “neutral” rating and cut their target price for the stock from $109.00 to $96.00 in a research report on Wednesday, January 2nd. ValuEngine cut shares of Medtronic from a “buy” rating to a “hold” rating in a research report on Monday, January 7th. JPMorgan Chase & Co. upgraded shares of Medtronic from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $100.00 to $109.00 in a research report on Wednesday, December 19th. Morgan Stanley lifted their target price on shares of Medtronic from $98.00 to $102.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 2nd. Finally, Deutsche Bank initiated coverage on shares of Medtronic in a research report on Wednesday, January 2nd. They set a “buy” rating and a $99.00 target price for the company. Nine equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. Medtronic currently has an average rating of “Buy” and an average price target of $104.32.

NYSE:MDT opened at $93.79 on Friday. The company has a quick ratio of 1.92, a current ratio of 2.36 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $125.79 billion, a PE ratio of 19.66, a PEG ratio of 2.40 and a beta of 0.82. Medtronic PLC has a 1-year low of $76.41 and a 1-year high of $100.15.

Medtronic (NYSE:MDT) last posted its quarterly earnings data on Tuesday, February 19th. The medical technology company reported $1.29 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.05. The business had revenue of $7.55 billion during the quarter, compared to analyst estimates of $7.53 billion. Medtronic had a net margin of 16.10% and a return on equity of 13.85%. The company’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.17 earnings per share. Research analysts anticipate that Medtronic PLC will post 5.15 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 12th. Stockholders of record on Friday, March 22nd will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.13%. The ex-dividend date is Thursday, March 21st. Medtronic’s dividend payout ratio is presently 41.93%.

COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Modern Readers and is the property of of Modern Readers. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.modernreaders.com/news/2019/03/17/wisconsin-capital-management-llc-takes-1-52-million-position-in-medtronic-plc-mdt.html.

About Medtronic

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.

Read More: Dividend

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.